FYN and obesity due to melanocortin 4 receptor deficiency: Therefore, targeted inhibition of Fyn represents a potential novel strategy for reduction of adipose accumulation and alleviation of obesity, as well as a promising approach for treating type 2 diabetes mellitus and its complications.